[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fi7HVk7ZPSsngMLjZIEm1HQ81scNmdxvBnEcWkzl4yoI":3},{"_id":4,"category":5,"content":9,"date":10,"heroImage":9,"newsPageBuilder":11,"seo":9,"slug":59,"title":60},"3331b40e-a8e1-487d-b862-8142342031f2",{"_id":6,"slug":7,"title":8},"c098646c-9061-4278-96a9-6a3e9a140b5a","events","Events",null,"2022-03-14T00:00:00.000Z",[12],{"_key":13,"_type":14,"content":15},"nc15","newsContent",[16,27,35,43,51],{"_key":17,"_type":18,"children":19,"markDefs":25,"style":26},"b15p1","block",[20],{"_key":21,"_type":22,"marks":23,"text":24},"s15p1","span",[],"KLISBio, a regenerative medicine company utilizing silk-based technology, announced its participation in the LSI 2022 Emerging MedTech Summit scheduled for March 15-18, 2022 in Dana Point, California. Jason Schense, the company's Chief Business Officer and Chief Operating Officer, represented the organization at the event.",[],"normal",{"_key":28,"_type":18,"children":29,"markDefs":34,"style":26},"b15p2",[30],{"_key":31,"_type":22,"marks":32,"text":33},"s15p2",[],"The company aims to establish partnerships with investors and industry stakeholders while promoting SILKBridge, its lead product candidate for peripheral nerve repair. This device consists of purified Bombyx mori silk fibroin and is designed to repair peripheral nerve gaps while supporting tissue regeneration. The product is anticipated to reach the U.S. market in 2023.",[],{"_key":36,"_type":18,"children":37,"markDefs":42,"style":26},"b15p3",[38],{"_key":39,"_type":22,"marks":40,"text":41},"s15p3",[],"According to leadership: \"KLISBio is focused on developing innovative solutions to tackle prominent unmet clinical needs through a silk-based multidisciplinary technology platform.\"",[],{"_key":44,"_type":18,"children":45,"markDefs":50,"style":26},"b15p4",[46],{"_key":47,"_type":22,"marks":48,"text":49},"s15p4",[],"The organization's leadership includes experienced professionals in medical technology and biomedical engineering. The company holds patents covering silk fibroin compositions, silk-based composites, and core-shell silk nanofiber structures.",[],{"_key":52,"_type":18,"children":53,"markDefs":58,"style":26},"b15p5",[54],{"_key":55,"_type":22,"marks":56,"text":57},"s15p5",[],"Beyond SILKBridge, KLISBio is developing additional products targeting vascular grafts, bone substitutes, and rotator cuff repair applications, all based on natural silk fibroin technology.",[],"klisbio-biotech-lsi-2022","KLISBio to share innovative tissue-engineered technology at LSI 2022 Emerging MedTech Summit"]